UK: AstraZeneca sells Quorn to Montagu Private Equity
Anglo-Swedish pharmaceuticals group AstraZeneca has sold Quorn, a leading brand of vegetarian meat-substitute products, to Montagu Private Equity for £70m (US$115.1m). AstraZeneca put Marlow Foods, which makes and distributes Quorn, up for sale a year ago, when the business was estimated to be worth around £100m, reported the Financial Times.
Get full access to all content, just $1 for 30 days
A Message From The Editor
just-food gives you the widest food market coverage.
Paid just-food members have unlimited access to all our exclusive content - including 17 years of archives.
It’s our best ever membership offer – just for you.
Dean Best, editor of just-food
- Comment: Premier has more to ponder than Brexit
- 2017: three major drivers of M&A strategy
- The food market in 2017 - consumer trends and M&A
- Trump seen as negative for global food trade
- Analysis: B&G Foods balancing growth and decline
- Premier Foods issues profit warning
- Nestle mum on Mead Johnson takeover talk
- Mondelez sells Vegemite to Bega
- Kellogg to slash 250 jobs
- Emmi to buy dessert maker Italian Fresh Foods